Related Experiment Video
Updated: May 29, 2026

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
Published on: September 9, 2020
Cardiac rupture in takotsubo cardiomyopathy: a systematic review
Sanjay Kumar1, Sashank Kaushik, Amit Nautiyal
1Department of Cardiovascular Medicine, SUNY Downstate Medical Center, Brooklyn, New York 11203, USA. kumarsanjay@sbcglobal.net
Insights
Cardiac rupture (CR) in Takotsubo cardiomyopathy (TSC) is more common than thought. Older female patients with higher ejection fraction and double product are at risk. Beta-blocker use may prevent CR.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Takotsubo cardiomyopathy (TSC) is increasingly recognized.
- Cardiac rupture (CR) is a rare but fatal complication of TSC.
- Identifying risk factors for CR in TSC is crucial for patient management.
Purpose of the Study:
- To compare demographic and clinical characteristics of TSC patients with and without cardiac rupture.
- To identify predictors of cardiac rupture in Takotsubo cardiomyopathy.
Main Methods:
- Literature search of MEDLINE for Takotsubo cardiomyopathy with cardiac rupture case reports.
- Comparison of 12 TSC with CR cases against 12 randomly selected TSC without CR cases.
- Analysis of demographic and clinical data, including ECG findings and hemodynamic parameters.
Main Results:
- Patients with TSC and CR were significantly older and predominantly female.
- Higher frequency of ST elevation (lead II) and absence of T-wave inversion (lead V5) on admission in the CR group.
- Elevated ejection fraction, systolic blood pressure, and double product were observed in the CR group.
- Less frequent use of beta-blockers in patients who developed CR.
Conclusions:
- Cardiac rupture may be an under-recognized complication of Takotsubo cardiomyopathy.
- Higher intracardiac pressure fluctuations, indicated by elevated double product and ejection fraction, may contribute to CR.
- Beta-blocker therapy might offer protective benefits against cardiac rupture in TSC patients.
Background:
Takotsubo cardiomyopathy (TSC) and its complications, such as cardiac rupture (CR), are increasingly being reported in the literature. CR is associated with rapid clinical decline and is uniformly fatal if not surgically repaired. To identify patients who developed CR we performed an analysis of all available indexed cases in the literature and compared them with a control group of patients with TSC without rupture.
Hypothesis:
Takotsubo cardiomyopathy patients with cardiac rupture do not differ significantly from those without rupture.
Methods:
MEDLINE (2009) was searched for all TSC case reports with CR. Eleven case reports were identified. Using a random sampling method, we selected 12 case reports of TSC without rupture (control). We included our patient with TSC with rupture as the 12th case of TSC cohort with CR (CR group). Demographic and clinical characteristics were compared between CR group and control.
Results:
All patients in the TSC group with rupture were female and were significantly older than controls. TSC group with rupture had significantly higher frequency of ST elevation in lead II and absence of T-wave inversion in lead V5 on hospital admission than controls. Mean ejection fraction, systolic blood pressure, and double product, a measure of oxygen demand, was significantly higher in the rupture group compared to controls. The CR group was associated with less frequent use of β-blocker as compared to controls.
Conclusions:
CR as a complication of TSC could be more common than recognized. Higher double product and ejection fraction suggest higher fluctuation of intracardiac pressure and may cause CR in TSC. Use of β blockers in TSC may provide protection against CR.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care
Introduction Cardiac Emergencies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies

